For type 2 diabetes mellitus. ANDA 75972, held by Chartwell. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 75972 (Metformin Hydrochloride), held by Chartwell, was first approved by FDA on Jan 24, 2002, with 7 approved supplements and 0 published complete response letters.
Metformin hydrochloride tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 24, 2002 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride850MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride1GM · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride750MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride625MG · tablet;oral | Metformin Hydrochloride | Rx |
| Aug 11, 2026 | Supplement 33Labeling · Standard review | Approved | None posted |
| Jun 20, 2026 | Supplement 32Labeling · Standard review | Approved | None posted |
| Jun 20, 2026 | Supplement 31Labeling · Standard review | Approved | None posted |
| Oct 9, 2008 | Supplement 29Labeling | Approved | None posted |
| Feb 12, 2008 | Supplement 24Labeling | Approved | None posted |
| Mar 30, 2004 | Supplement 7Labeling | Approved | None posted |
| Aug 19, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Jan 24, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters